WallStreetZenWallStreetZen

NASDAQ: RDNT
RADNET INC Stock Forecast, Predictions & Price Target

Analyst price target for RDNT

Based on 1 analyst offering 12 month price targets for RADNET INC.
Min Forecast
$39.00+102.28%
Avg Forecast
$39.00+102.28%
Max Forecast
$39.00+102.28%

Should I buy or sell RDNT stock?

Based on 2 analysts offering ratings for RADNET INC.
Buy
Strong Buy
1 analysts 50%
Buy
0 analysts 0%
Hold
1 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

RDNT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Raymond James
Top 39%
62
HoldDowngradesN/AN/A2021-08-12
Barclays
Bottom 9%
9
Strong BuyInitiates Coverage On$39.00+102.28%2021-08-12

1 of 1

Forecast return on equity

Is RDNT forecast to generate an efficient return?
Company
10.91%
Industry
65.87%
Market
34.95%
RDNT's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is RDNT forecast to generate an efficient return on assets?
Company
1.52%
Industry
10.17%
RDNT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

RDNT earnings per share forecast

What is RDNT's earnings per share in the next 2 years based on estimates from 2 analysts?
Avg 1 year Forecast
$0.20-39.39%
Avg 2 year Forecast
$0.58+75.76%
RDNT's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

RDNT revenue forecast

What is RDNT's revenue in the next 2 years based on estimates from 2 analysts?
Avg 1 year Forecast
$1.4B+3.75%
Avg 2 year Forecast
$1.5B+8.56%
RDNT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

RDNT earnings growth forecast

How is RDNT forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
-39.39%
Industry
19.82%
Market
37.65%
RDNT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
RDNT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
RDNT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

RDNT revenue growth forecast

How is RDNT forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
3.75%
Industry
3.19%
Market
12.79%
RDNT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
RDNT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

RDNT vs Diagnostics & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
RDNT$19.28$39.00+102.28%Buy
VIVO$25.97$30.00+15.52%Buy
HSKA$95.17$221.00+132.22%Strong Buy
NEO$7.77$30.13+287.71%Strong Buy
PACB$5.39$29.00+438.03%Buy

RADNET Stock Forecast FAQ

Is RADNET Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: RDNT) stock is to Buy RDNT stock.

Out of 2 analysts, 1 (50%) are recommending RDNT as a Strong Buy, 0 (0%) are recommending RDNT as a Buy, 1 (50%) are recommending RDNT as a Hold, 0 (0%) are recommending RDNT as a Sell, and 0 (0%) are recommending RDNT as a Strong Sell.

What is RDNT's earnings growth forecast for 2022-2023?

(NASDAQ: RDNT) RADNET's forecast annual earnings growth rate of -39.39% is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 19.82%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 37.65%.

RADNET's earnings in 2022 is $18,283,000.On average, 2 Wall Street analysts forecast RDNT's earnings for 2022 to be $11,243,895, with the lowest RDNT earnings forecast at $8,432,921, and the highest RDNT earnings forecast at $13,492,674.

In 2023, RDNT is forecast to generate $32,607,294 in earnings, with the lowest earnings forecast at $26,423,152 and the highest earnings forecast at $38,791,436.

What is RDNT's revenue growth forecast for 2022-2023?

(NASDAQ: RDNT) RADNET's forecast annual revenue growth rate of 3.75% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 3.19%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.79%.

RADNET's revenue in 2022 is $1,341,524,000.On average, 2 Wall Street analysts forecast RDNT's revenue for 2022 to be $78,249,354,592, with the lowest RDNT revenue forecast at $77,867,905,468, and the highest RDNT revenue forecast at $78,630,803,717.

In 2023, RDNT is forecast to generate $81,876,353,893 in revenue, with the lowest revenue forecast at $81,784,716,152 and the highest revenue forecast at $81,967,991,634.

What is RDNT's forecast return on assets (ROA) for 2022-2023?

(NASDAQ: RDNT) forecast ROA is 1.52%, which is lower than the forecast US Diagnostics & Research industry average of 10.17%.

What is RDNT's Price Target?

According to 1 Wall Street analyst that have issued a 1 year RDNT price target, the average RDNT price target is $39.00, with the highest RDNT stock price forecast at $39.00 and the lowest RDNT stock price forecast at $39.00.

The Wall Street analyst predicted that RADNET's share price could reach $39.00 by Aug 12, 2022. The average RADNET stock price prediction forecasts a potential upside of 102.28% from the current RDNT share price of $19.28.

What is RDNT's Earnings Per Share (EPS) forecast for 2022-2023?

(NASDAQ: RDNT) RADNET's current Earnings Per Share (EPS) is $0.33. On average, analysts forecast that RDNT's EPS will be $0.20 for 2022, with the lowest EPS forecast at $0.15, and the highest EPS forecast at $0.24. In 2023, RDNT's EPS is forecast to hit $0.58 (min: $0.47, max: $0.69).

What is RDNT's forecast return on equity (ROE) for 2022-2023?

(NASDAQ: RDNT) forecast ROE is 10.91%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.